Clinical Trial

guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing

Study acronym: guideSEQ
Recruiting
View on ClinicalTrials.gov →
Summary
This study looks at whether genome sequencing should be used more routinely during pregnancy, even when ultrasounds look normal. Genome sequencing can examine nearly all of a baby's genes and may find genetic conditions that standard tests do not detect. Researchers will compare this test with current prenatal testing to see if it provides helpful information for families and doctors. The study will also explore how parents decide what kinds of genetic information they want to receive and how this information affects their experience during pregnancy. The goal is to understand whether genome sequencing can be used in a way that is helpful, responsible, and supportive for families in the future.
Protocol Amendment History 1 change
critical Phase changed: not specified -> not applicable 2026-07-16
Trial Details
NCT Number NCT07610590
Lead Sponsor Columbia University
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Prenatal Genetic Diagnosis
Enrollment 1,042 participants
Start Date 2026-04-29
Primary Completion 2029-07-31 (estimated)
Study Completion 2029-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-15